Data Integrity, ALCOA+ & Part 11 / Annex 11

Audit Trail Review in GMP: Designing a Practical, Risk-Based Program Audit Trail Review in GMP: Designing a Practical, Risk-Based Program In the pharmaceutical manufacturing industry, maintaining data integrity is a foundational regulatory expectation demanded by authorities such as the FDA, EMA, and MHRA. Integral to this objective is the implementation of effective and practical audit…

Read More “Audit Trail Review in GMP: Designing a Practical, Risk-Based Program” »

Common Data Integrity Failures in QC Labs and How to Prevent Them Understanding and Preventing Common Data Integrity Failures in QC Laboratories Data integrity is a foundation stone in pharmaceutical manufacturing and quality control. Ensuring the accuracy, completeness, and reliability of data generated in Quality Control (QC) laboratories supports compliance with GxP principles and regulatory…

Read More “Common Data Integrity Failures in QC Labs and How to Prevent Them” »

How to Perform a Data Integrity Risk Assessment for Critical GMP Systems Step-by-Step Guide: Performing a Data Integrity Risk Assessment for Critical GMP Systems Ensuring data integrity is a fundamental requirement within pharmaceutical Good Manufacturing Practice (GMP). Considering the regulatory mandates under 21 CFR Part 11 in the US, Annex 11 in the EU, and…

Read More “How to Perform a Data Integrity Risk Assessment for Critical GMP Systems” »

Building a Site-Wide Data Integrity Governance Model for GMP Environments Step-by-Step Guide to Building a Site-Wide Data Integrity Governance Model for GMP Environments In the pharmaceutical industry, maintaining data integrity across all manufacturing and control systems is a regulatory imperative and a cornerstone of product quality and patient safety. Robust governance models enable organizations to…

Read More “Building a Site-Wide Data Integrity Governance Model for GMP Environments” »

Data Integrity 101 in Pharma: Applying ALCOA+ Across All GxP Records Ensuring Complete Data Integrity by Applying ALCOA+ in Pharmaceutical GxP Records Data integrity is a fundamental principle in pharmaceutical manufacturing and clinical operations, underpinning regulatory compliance, product quality, and patient safety. The concept of data integrity extends beyond mere accuracy to encompass completeness, consistency,…

Read More “Data Integrity 101 in Pharma: Applying ALCOA+ Across All GxP Records” »

Controlling Shared Logins and Unauthorized Access in GxP Computer Systems Step-by-Step Tutorial: Managing Shared Logins and Preventing Unauthorized Access in GxP Computer Systems Maintaining data integrity in regulated pharmaceutical environments demands rigorous control of user access to electronic systems. Shared logins and unauthorized access pose significant risks to the trustworthiness of GxP records, potentially violating…

Read More “Controlling Shared Logins and Unauthorized Access in GxP Computer Systems” »

Detecting and Investigating Backdating and Record Reconstruction in GMP Detecting and Investigating Backdating and Record Reconstruction in GMP: A Step-by-Step Tutorial Maintaining data integrity is paramount within pharmaceutical Good Manufacturing Practice (GMP) environments. The risks posed by intentional or unintentional manipulation of GxP records compromise not only regulatory compliance but also product quality and patient…

Read More “Detecting and Investigating Backdating and Record Reconstruction in GMP” »

Data Integrity Remediation After an MHRA or FDA Inspection: Step-by-Step Approach Step-by-Step Guide to Data Integrity Remediation After an MHRA or FDA Inspection Ensuring robust data integrity is paramount for pharmaceutical manufacturers and related stakeholders in the United States, United Kingdom, and European Union. Regulatory authorities such as the FDA, MHRA, and EMA place significant…

Read More “Data Integrity Remediation After an MHRA or FDA Inspection: Step-by-Step Approach” »

Managing Hybrid Paper–Electronic Systems Without Compromising Data Integrity Step-by-Step Guide to Managing Hybrid Paper–Electronic Systems Without Compromising Data Integrity In the pharmaceutical industry, maintaining data integrity across all forms of recording media is critical to product quality, regulatory compliance, and patient safety. Hybrid paper–electronic systems—where both paper and electronic records coexist—remain prevalent in many pharmaceutical…

Read More “Managing Hybrid Paper–Electronic Systems Without Compromising Data Integrity” »

Applying ALCOA+ Principles to Paper Records in High-Volume Operations Step-by-Step Guide to Applying ALCOA+ Principles to Paper Records in High-Volume Pharmaceutical Operations Maintaining robust data integrity is critical in pharmaceutical manufacturing and related operations. The regulatory expectations set forth by authorities such as the FDA, EMA, and MHRA emphasize adherence to ALCOA+ principles to ensure…

Read More “Applying ALCOA+ Principles to Paper Records in High-Volume Operations” »